U.S. pharma giant copyright scrapped two experimental weight loss tablets past yr—a the moment-everyday tablet, lotiglipron, as a consequence of elevated liver enzymes and also a 2 times-every day pill, danuglipron, as a result of solid Unintended effects—but CEO Albert Bourla has claimed the company is decided to “play and get” during the